Fulcrum Therapeutics, Inc. - FULC

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 24
Latest filed: Jun 04, 2026
Form Count
4 9
8-K 7
SCHEDULE 13G/A 5
144 2
4/A 1

Latest files

Filed Form Report period Accession SEC
Jun 04, 2026 8-K May 31, 2026 0001193125-26-257376 View
Jun 01, 2026 8-K Jun 01, 2026 0001193125-26-251394 View
May 15, 2026 SCHEDULE 13G/A 0001104659-26-062675 View
May 15, 2026 SCHEDULE 13G/A 0001193125-26-226891 View
May 01, 2026 4 Apr 23, 2026 0001193125-26-201468 View
Apr 27, 2026 8-K Apr 23, 2026 0001193125-26-178806 View
Mar 26, 2026 SCHEDULE 13G/A 0000102909-26-001344 View
Feb 24, 2026 8-K Feb 24, 2026 0001193125-26-065190 View
Feb 17, 2026 SCHEDULE 13G/A 0001346824-26-000043 View
Feb 04, 2026 4 Feb 02, 2026 0001193125-26-037572 View
Feb 04, 2026 4 Feb 02, 2026 0001193125-26-037575 View
Feb 04, 2026 4 Feb 02, 2026 0001193125-26-037573 View
Feb 04, 2026 4 Feb 02, 2026 0001193125-26-037574 View
Feb 04, 2026 4 Feb 02, 2026 0001193125-26-037576 View
Feb 04, 2026 4/A Jan 02, 2026 0001193125-26-037606 View
Jan 12, 2026 8-K Jan 12, 2026 0001193125-26-009845 View
Jan 06, 2026 4 Jan 02, 2026 0001193125-26-004572 View
Dec 17, 2025 4 Dec 15, 2025 0001193125-25-322740 View
Dec 15, 2025 144 0001950047-25-010350 View
Dec 11, 2025 8-K Dec 10, 2025 0001193125-25-314728 View
Dec 10, 2025 SCHEDULE 13G/A 0001346824-25-000068 View
Dec 10, 2025 4 Dec 08, 2025 0001231919-25-000596 View
Dec 08, 2025 8-K Dec 08, 2025 0001193125-25-310509 View
Dec 08, 2025 144 0001178937-25-000086 View